Answers are grounded in this paper and cite their sources.
In treating locally advanced non-small-cell lung cancer (NSCLC), radiotolerance of the normal lung often limits the amount of dose that can be delivered to the primary cancer site. Radiation-related pneumonitis (RP) and other normal lung tissue complications have a significant impact on clinical outcome and patient quality of life. How to minimize treatment side effects while achieving desirable local control of lung cancers has been a continuous challenge.
No takes yet. Share an insight, caveat, or question.
Xiao Wang (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: